@dviceST @TuckerBlows Or the preclinical trials that were run by the NCI using each of the drugs individually and in multiple combinations which is the start of the impressive triple combo therapy data. Can't wait to see design, hope $PDSB includes a CPI r
@edenbiocell @gth829c Link to article in previous $pdsb tweet. Next week's data for refractory arm is from up to 21 patients who were refractory to CPI in H&N cancer when combining PDS0101 w $mrk Keytruda. Mgt stated these data will help design P3 trip
$pdsb posted over on Stocktwits https://t.co/jouGOJ1f9A Article reference link: https://t.co/Q4Nhm8Qw5T https://t.co/8OXvSOYt9k
RT @DesertDweller93: @Pharmdca Reminder of how the individual and combinations stack up in $pdsb preclinical trial. Granted, it's preclinic…